Showing results (41-50 of 215) with videos related to
Sort By:
Pageof 22
Expert Opinion on Biological Therapy|September 26, 2017
Advances in immunotherapy for pediatric acute myeloid leukemiaChallice L Bonifant, Mireya Paulina Velasquez, Stephen GottschalkFrontiers in Immunology|January 25, 2021
Allogeneic CAR Cell Therapy-More Than a Pipe DreamKenneth J Caldwell, Stephen Gottschalk, Aimee C TalleurMolecular Therapy : the Journal of the American Society of Gene Therapy|September 26, 2020
CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?Jessica Wagner, Elizabeth Wickman, Christopher DeRenzo, et al.Current Topics in Microbiology and Immunology|May 27, 2026
Adoptive T-Cell ImmunotherapyStephen Gottschalk, Catherine M Bollard, Cliona M RooneyImmunological Reviews|December 17, 2013
Design and development of therapies using chimeric antigen receptor-expressing T cellsGianpietro Dotti, Stephen Gottschalk, Barbara Savoldo, et al.Nature Immunology|July 18, 2024
T cell dysfunction and therapeutic intervention in cancerCaitlin C Zebley, Dietmar Zehn, Stephen Gottschalk, et al.Frontiers in Oncology|January 16, 2014
Genetically modified T cells to target glioblastomaSimone Krebs, Tania G Rodríguez-Cruz, Christopher Derenzo, et al.Cancers|September 10, 2021
Cytolytic Activity of CAR T Cells and Maintenance of Their CD4+ Subset Is Critical for Optimal Antitumor Activity in Preclinical Solid Tumor ModelsMarianna Csaplár, János Szöllősi, Stephen Gottschalk, et al.Infection and Immunity|May 24, 2005
Peripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosisSuraj B Sable, Rajnish Kumar, Mamta Kalra, et al.Methods in Molecular Biology (Clifton, N.J.)|November 23, 2016
EBV-Directed T Cell Therapeutics for EBV-Associated LymphomasLauren P McLaughlin, Stephen Gottschalk, Cliona M Rooney, et al.Pageof 22